Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 80OTHER 49NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Neoplasm Metastasis 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostate Cancer Metastatic 1Oropharyngeal Neoplasms 1Oligometastatic Squamous Cell Carcinoma of the Head and Neck 1Neoplasm, Residual 1Mouth Neoplasms 1Mesothelioma 1Melanoma 1Leukemia, Myeloid, Chronic-Phase 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Hodgkin Disease 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Carcinoma 1Breast Neoplasms 1Biliary Tract Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Gemcitabine 3Carboplatin 3cabozantinib 2Magnetic Resonance Spectroscopy 2Interferon-alpha 2Granulocyte Colony-Stimulating Factor 2Gene Expression Profiling 2Filgrastim 2Etoposide 2Doxorubicin 2Cyclophosphamide 2tumor necrosis factor-alpha, CNGRC fusion protein, human 1siltuximab 1pembrolizumab 1peginterferon alfa-2b 1pegfilgrastim 1pazopanib 1lenvatinib 1fludarabine 1aldesleukin 1Vincristine 1Thrombopoietin 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Renal Cell × pembrolizumab × Clear all
NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡